| Product Information |
|
| Registration Number |
DRP-13185
|
| Generic Name |
Etoposide
|
| Brand Name |
Etosaphside
|
| Dosage Strength |
20 mg/mL (50 mg/2.5 mL, 100 mg/5 mL and 200
mg/10 mL)
|
| Dosage Form |
Solution For I.V Injection
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antineoplastic (Podophyllotoxin Derivative)
|
| Packaging |
USP Type I Clear Glass Vial (2.5 mL, 5 mL & 10 mL net content) [Box of 1's]
|
| Manufacturer |
Bruck Pharma Private Limited
|
| Country of Origin |
India
|
| Trader |
Sapphire Lifesciences Pvt. Ltd.
|
| Importer |
Nelpa Lifesciences, Inc.
|
| Distributor |
Nelpa Lifesciences, Inc.
|
| Application Type |
Initial
|
| Issuance Date |
22 December 2022
|
| Expiry Date |
22 December 2027
|